Bone Biologics Corporation (BBLG)
NASDAQ: BBLG · Real-Time Price · USD
1.320
+0.015 (1.15%)
At close: May 29, 2026, 4:00 PM EDT
1.335
+0.015 (1.12%)
After-hours: May 29, 2026, 7:11 PM EDT
Bone Biologics Market Cap
Bone Biologics has a market cap or net worth of $2.37 million as of May 29, 2026. Its market cap has decreased by -6.52% in one year.
Market Cap
2.37M
Enterprise Value
-2.16M
1-Year Change
-6.52%
Ranking
Category
Stock Price
$1.32
Market Cap Chart
Since March 31, 2016, Bone Biologics's market cap has decreased from $155.72M to $2.37M, a decrease of -98.48%. That is a compound annual growth rate of -33.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 28, 2026 | 2.34M | -10.00% |
| Dec 31, 2025 | 2.60M | 12.38% |
| Dec 31, 2024 | 2.32M | -4.06% |
| Dec 29, 2023 | 2.41M | -24.75% |
| Dec 30, 2022 | 3.21M | -91.19% |
| Dec 31, 2021 | 36.43M | -58.55% |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 23, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| GRI Bio | 3.03M |
| Calidi Biotherapeutics | 2.94M |
| Ensysce Biosciences | 2.78M |
| Valion Bio | 2.76M |
| Oragenics | 2.66M |
| Clearmind Medicine | 2.53M |
| SciSparc | 2.52M |
| Biodexa Pharmaceuticals | 2.13M |